Lin, C C <br/><br/>
Long-term evaluation of recombinant interferon alpha2b in the treatment of patients with hepatitis B e antigen-negative chronic hepatitis B in Taiwan.  [electronic resource] 

 -  Journal of viral hepatitis  Nov 2001 
 - 438-46 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-0504 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2893.2001.00320.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Case-Control Studies<br/>Female<br/>Follow-Up Studies<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Taiwan